Tag: before-breast
-
Roche breast cancer drug Perjeta rejected by NICE
Roche's breast cancer drug Perjeta, or pertuzumab, has been turned down for use on Britain's state health service, making it the latest in a number of pricey new cancer treatments deemed not to offer value for money. The National Institute for Health and Care Excellence (NICE) said in draft guidance on Friday that it could…
-
Roche breast cancer drug Perjeta rejected by NICE
Roche's breast cancer drug Perjeta, or pertuzumab, has been turned down for use on Britain's state health service, making it the latest in a number of pricey new cancer treatments deemed not to offer value for money. The National Institute for Health and Care Excellence (NICE) said in draft guidance on Friday that it could…
-
Yellow fever outbreaks in Africa need action, mass vaccination – WHO
By Stephanie Nebehay GENEVA (Reuters) – Outbreaks of deadly yellow fever in Angola and the Democratic Republic of Congo do not constitute a global health emergency but require stepped-up control measures and mass vaccination, the World Health Organisation (WHO) said on Thursday. “This can be a devastating disease with rapid spread particularly in urban areas,”…
-
Yellow fever outbreaks in Africa need action, mass vaccination – WHO
By Stephanie Nebehay GENEVA (Reuters) – Outbreaks of deadly yellow fever in Angola and the Democratic Republic of Congo do not constitute a global health emergency but require stepped-up control measures and mass vaccination, the World Health Organisation (WHO) said on Thursday. “This can be a devastating disease with rapid spread particularly in urban areas,”…
-
What does the world know about rescued Chibok schoolgirl Amina Ali?
The rescue of one of more than 200 Nigerian schoolgirls abducted by the Islamist group Boko Haram from a secondary school in Chibok in northeastern Nigeria two years has thrown global attention onto Amina Ali. President Muhammadu Buhari vowed at a news conference on Thursday that Ali would continue her education and condemned the brutality…